Insider · CIK 0001878075
Niklason Laura E
ceopresidentofficerdirector
Files at HUMA (Humacyte, Inc.). First filing Nov 20, 2024, latest Nov 21, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$7,979 bought, $6.6M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 28Weak | buy 2 | HUMA Humacyte, Inc. | $7,979 | 1,797 | +1% | - | |
| 68Notable | sell 2 | HUMA Humacyte, Inc. | $6.6M | 1,500,000 | -46% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | HUMA Humacyte, Inc. | AGrant or award Stock Options (right to buy)derivative | +525 | $0.00 | $0 | 2,625 | Dec 20, 2024 |
| Nov 19, 2024 | HUMA Humacyte, Inc. | POpen-market purchase Common Stock | +1,797 | $4.44 | $7,979 | 243,851 | Nov 21, 2024 |
| Nov 18, 2024 | HUMA Humacyte, Inc. | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -811,172 | $4.44 | $3.6M | 2,419,712 | Nov 20, 2024 |
| Nov 19, 2024 | HUMA Humacyte, Inc. | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -427,459 | $4.34 | $1.9M | 1,992,253 | Nov 20, 2024 |
| Nov 20, 2024 | HUMA Humacyte, Inc. | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -261,369 | $4.40 | $1.2M | 1,730,884 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.